Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei

APMIS

Volumn 105, Issue 8, 1997, Pages 643-649

  Matsuzaki, Takeshi ^a   Nagata, Yuriko ^a   Kado, Shouichi ^a   Uchida, Kazumi ^a   Kato, Ikuo ^a   Hashimoto, Shusuke ^a   Yokokura, Teruo ^a  

^a YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Cytokine production; Lactobacillus casei; Langerhans islets; NOD mice; Oral feeding

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FOOD INTAKE; HISTOPATHOLOGY; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; LACTOBACILLUS CASEI; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0030801225     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1997.tb05066.x     Document Type: Article

References (30)

1. Bach, J.-F.: Strategies in immunotherapy of insulin-dependent diabetes mellitus. Ann. N.Y. Acad. Sci. 696: 364-376, 1993.
2. Bottazzo, G. F.: β-cell damage in diabetic insulitis: are we approaching a solution? Diabetologia 26: 241-249, 1984.
3. Campbell, I. L., Kay, T. W. H., Oxbrow, L. & Harrison, L. C.: Essential role for interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 87: 739-742, 1991.
4. Charlton, B., Bacelj, A. & Mandel, T. E.: Administration of silica particles or anti-Lyt2 antibody prevents β-cell destruction in NOD mice given cyclophosphamide. Diabetes 37: 930-935, 1988.
5. Gepts, W. & Lecompte, P. M.: The pancreatic islets in diabetes. Am. J. Med. 70: 105-115, 1981.
6. Harada, M., Kishimoto, Y. & Makino, S.: Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Res. Clin. Pract. 8: 85-89, 1990.
7. Jacob, C. O., Aiso, S., Michie, S. A., McDevitt, H. O. & Acha-Orbea, H.: Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): Similarities between TNF-α and interleukin 1. Proc. Natl. Acad. Sci. 87: 968-972, 1990.
8. Kanazawa, Y., Kameda, K., Sato, S., Mori, S., Akamura, K. & Takuka, F.: Non-obese diabetic mice: Immune mechanisms of pancreatic β-cell destruction. Diabetologia 27: 113-115, 1984.
9. Kataoka, S., Satoh, J., Fujiya, H., Toyota, T., Suzuki, R., Itoh, K. & Kumagai, K.: Immunologic aspects of the nonobese diabetic (NOD) mouse. Diabetes 32: 247-253, 1983.
10. Kato, I., Kobayashi, S., Yokokura, T. & Mutai, M.: Antitumor activity of Lactobacillus casei in mice. Gann 72: 517-523, 1981.
11. Kato, I., Endo, K. & Yokokura, T.: Effects of oral administration of Lactobacillus casei on antitumor responses induced by tumor resection in mice. Int. J. Immunopharmacol. 16: 29-36, 1994.
12. Katz, J. D., Benoist, C. & Mathis, D.: T helper cell subsets in insulin-dependent diabetes. Science 268: 1185-1188, 1995.
13. Koike, T., Itoh, Y., Ishii, T., Itoh, I., Takabayashi, K., Maruyama, M., Tomioka, H. & Yoshida, S.: Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes 36: 539-541, 1987.
14. Makino, S., Kunimoto, K., Muraoka, Y., Mizushima, Y., Katagiri, K. & Tochima, Y.: Breeding of non-obese diabetic strain of mice. Exp. Anim. 29: 1-13, 1980.
15. Makino, S., Harada, M., Kishimoto, Y. & Hayashi, Y.: Absence of insulitis and overt diabetes in athymic nude mice with NOD genetic background. Exp. Anim. 35: 495-498, 1986.
16. Mandrup-Poulsen, T., Bendtzen, K., Nerup, J., Dinarello, C. A., Svenson, M. & Nielson, J. H.: Affinity-purified human interleukin 1 is cytotoxic to isolated islets of Langerhans. Diabetologia 29: 63-67, 1986.
17. Mandrup-Poulsen, T., Bendtzen, K., Dinarello, C. A. & Nerup, J.: Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic β-cell cytotoxicity. J. Immunol. 139: 4077- 4082, 1987.
18. Maruyama, T., Takei, I., Taniyama, M., Kataoka, K. & Matsui, S.: Immunological aspect of non-obese diabetic mice: immune islet cell-killing mechanism and cell-mediated immunity. Diabetologia 27: 121-123, 1984.
19. Masuno, T., Kishimoto, S., Ogura, T., Honma, T., Niitani, H., Fukuoka, M. & Ogawa, N.: Control of carcinomatous pleural effusion with LC 9018 and quality of life in lung cancer patients. Biotherapy : 847-856, 1994 (in Japanese).
20. Matsuzaki, T., Yokokura, T. & Azuma, I.: Antitumor activity of Lactobacillus casei on Lewis lung carcinoma and line-10 hepatoma in syngeneic mice and guinea pigs. Cancer Immunol. Immunother. 20: 18-22, 1985.
21. Matsuzaki, T., Yokokura, T. & Azuma, I.: Antimetastatic effect of Lactobacillus casei YIT9018 (LC 9018) on a highly metastatic variant of B16 melanoma in C57BL/6J mice. Cancer Immunol. Immunother. 24: 99-105, 1987.
22. Matsuzaki, T., Shimizu, Y. & Yokokura, T.: Augmentation of antimetastatic effect on Lewis lung carcinoma (3LL) in C57BL/6 mice by priming with Lactobacillus casei. Med. Microbiol. Immunol. 179: 161-168, 1990.
23. Matsuzaki, T., Nagata, Y., Kado, S., Uchida, K., Hashimoto, S. & Yokokura, T.: Effect of oral administration of Lactobacillus casei on alloxan-induced diabetes in mice. APMIS 105: 637-642, 1997.
24. Mori, Y., Okudaira, H., Matsuba, I., Tsuruoka, A., Sasaki, A., Yokoyama, H., Tanase, T., Shida, T., Nishimura, M., Terada, E. & Ikeda, Y.: Preventive effects of cyclosporin on diabetes in NOD mice. Diabetologia 29: 244-247, 1986.
25. Pujol-Borrell, R., Todd, I., Doshi, M., Bottazzo, G. F., Sutton, R., Gray, D., Adolf, G. R. & Feldmann, M.: HLA class II induction in human islet cell by interferon-γ plus tumor necrosis factor or lymphotoxin. Nature 326: 304-406, 1987.
26. Sadelain, M. W. J., Qin, H.-Y., Lavzon, J. & Singh, B.: Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39: 583-589, 1990.
27. Shizuru, J. A., Taylor-Edwards, C., Banks, B. A., Gregory, A. K. & Fathman, C. G.: Immunotherapy of the nonobese diabetic mouse: Treatment with an antibody to T-helper lymphocytes. Science 240: 659-662, 1988.
28. Toyota, T., Satoh, J., Oya, K., Shintani, S. & Okano, T.: Streptococcal preparation (OK-432) inhibits development of type I diabetes in NOD mice. Diabetes 35: 496-499, 1986.
29. Yagi, H., Matsumoto, M., Kishimoto, Y., Makino, S. & Harada, M.: Possible mechanism of the preventive effect of BCG against diabetes mellitus in NOD mouse. II. Suppression of pathogenesis by macrophage transfer from BCG-vaccinated mice. Cell Immunol. 138: 142-144, 1991.
30. Yagi, H., Matsumoto, M., Suzuki, S., Misaki, R., Suzuki, R., Makino, S. & Harada, S.: Possible mechanism of the preventive effect of BCG against diabetes mellitus in NOD mouse. I.Generation of suppressor macrophages in spleen cells of BCG-vaccinated mice. Cell Immunol. 138: 130-141, 1991.